Medicine focuses almost entirely on fighting chronic diseases in a piecemeal fashion as symptoms develop. Instead, more efforts should be directed to promoting interventions that have the potential to prevent multiple chronic diseases and extend healthy lifespans.
Researchers writing in the journal Nature say that by treating the metabolic and molecular causes of human aging, it may be possible to help people stay healthy into their 70s and 80s.
In a commentary published July 24 in Nature, a trio of aging experts calls for moving forward with preclinical and clinical strategies that have been shown to delay aging in animals. In addition to promoting a healthy diet and regular exercise, these strategies include slowing the metabolic and molecular causes of human aging, such as the incremental accumulation of cellular damage that occurs over time.
The researchers, at Washington University School of Medicine in St. Louis, Brescia University in Italy, the Buck Institute for Aging and Research and the Longevity Institute at the University of Southern California, write that economic incentives in biomedical research and health care reward treating disease more than promoting good health.
The Latest on: Diseases of aging
via Google News
The Latest on: Diseases of aging
- COVID-19 highlights lung health gaps in Jackson, but a group of chest doctors is listeningon November 29, 2020 at 1:00 am
JACKSON • Challise Burciaga still remembers early country mornings with her grandmother in Amite County. When Grandma got up at dawn, Burciaga got up too.
- New gene therapy approach offers promise for treating eye diseaseon November 26, 2020 at 3:01 pm
Scientists from Trinity College Dublin have developed a new gene therapy approach that offers promise for one day treating an eye disease that leads to a progressive loss of vision and affects ...
- Simulations Identify New Way to Reverse Natural Aging Process in Cellson November 26, 2020 at 7:22 am
Turning off a newly identified enzyme could reverse a natural aging process in cells. Research findings by a KAIST team provide insight into the complex mechanism of cellular senescence and present a ...
- Deep Longevity Adds Partnership with My Care Express in Merrillville To Add Biomarkers of Aging and Longevityon November 26, 2020 at 12:20 am
Deep Longevity aging clocks are supported by a number of academic publications summarized in a recent review titled " BioHorology and biomarkers of aging: Current state-of-the-art, challenges and ...
- The FDA has approved the first drug to treat the rapid-aging disease progeriaon November 25, 2020 at 3:03 am
Children with a rare genetic disorder called progeria age quickly and often die before they are 15. A newly approved drug may give them more time.
- Deep Longevity adds partnership with My Care Express in Merrillville to add biomarkers of agingon November 24, 2020 at 9:00 pm
Deep Longevity added My Care Express Merriville to its growing longevity network. My Care Express physicians will get training in longevity medicine and interpret the AgeMetric™ reports incorporating ...
- FDA Approves First Treatment for Rare Childhood Aging Diseaseson November 23, 2020 at 6:46 pm
The U.S. Food and Drug Administration approved Eiger BioPharmaceuticals' Zokinvy for Hutchinson-Gilford Progeria Syndrome and processing-deficient Progeroid Laminopathies.
- FDA Approves Drug for Progeria, a Rare Disease Causing Rapid Aging in Childrenon November 23, 2020 at 10:12 am
The FDA approved the first treatment to reduce the risk of mortality from progeria, an extremely rare disease that causes rapid aging and death, usually by age 15. The approval was granted to Eiger ...
- FDA approves first drug, Eiger's Zokinvy, for rare rapid-aging diseaseon November 23, 2020 at 9:05 am
For a long time, children with the ultrarare genetic disease progeria, which causes rapid aging, didn’t have an FDA-approved therapy. But that's about to change. The FDA has approved Zokinvy to treat ...
- Proceeds from Priority Review Voucher Sale Will Fund Search for Cure for the Rapid Aging Disease Progeriaon November 23, 2020 at 5:23 am
PRNewswire/ -- The Progeria Research Foundation (PRF) today announced that it will receive half of the net proceeds of the sale of a Priority Review Voucher (PRV). Earlier today, Eiger ...
via Bing News